SCHEMBL24376227

SCHEMBL24376227

CCCCCC(O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A5 Q9Y345 1/20 0.52
▸ SIRT6 Q8N6T7 1/20 0.47
▸ SIRT1 Q96EB6 1/20 0.47
▸ FOLH1 Q04609 1/20 0.46
▸ TLR2 O60603 2/20 0.45
▸ GPR84 Q9NQS5 3/20 0.44
▸ FFAR1 O14842 1/20 0.44
▸ GNAI3 P08754 1/20 0.44
▸ GNAO1 P09471 1/20 0.44
▸ GNAI1 P63096 1/20 0.44
▸ NOD1 Q9Y239 3/20 0.42
▸ GSR P00390 1/20 0.42
▸ RNPEP Q9H4A4 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ LCK P06239 1/20 0.40
▸ PPARD Q03181 1/20 0.40
▸ ZDHHC20 Q5W0Z9 1/20 0.40
▸ ZDHHC2 Q9UIJ5 1/20 0.40
▸ GRIK1 P39086 1/20 0.39
▸ SLC1A2 P43004 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3389707 0.98 SLC6A5 (0.54) SLC6A5SIRT6SIRT1FOLH1TLR2
SCHEMBL29291292 0.92 FOLH1 (0.47) SLC6A5SIRT6SIRT1FOLH1TLR2
SCHEMBL28741345 0.83 FOLH1 (0.51) SLC6A5SIRT6SIRT1FOLH1TLR2
SCHEMBL24711906 0.83 FOLH1 (0.51) SLC6A5FOLH1GSRRNPEPACE
SCHEMBL28307135 0.83 SLC6A5 (0.54) SLC6A5SIRT6SIRT1FOLH1TLR2
SCHEMBL28307136 0.83 SLC6A5 (0.54) SLC6A5SIRT6SIRT1FOLH1TLR2
SCHEMBL2354618 0.81 FOLH1 (0.50) SLC6A5FOLH1GSRRNPEPACE
SCHEMBL11676314 0.81 GPR84 (0.53) GPR84FFAR1NOD1MAPTLCK
SCHEMBL19816805 0.81 NOD1 (0.47) SLC6A5GPR84FFAR1NOD1MAPT
SCHEMBL7050367 0.81 NOD1 (0.47) SLC6A5GPR84FFAR1NOD1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3988170-A1 FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES Novartis AG (CH) 2022-04-27 — — EP disclosed
Send feedback